Cipla | CIPLA - Current Liabilities

Stock Price
1,432.10
Daily Change
-4.60 -0.32%
Monthly
16.38%
Yearly
-4.52%
Q2 Forecast
1,401.45

Cipla reported INR62.97B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Arca Biopharma USD 16.63M 1.26M Mar/2026
aTyr Pharma USD 11.7M 101.49M Mar/2026
Bio Path USD 8.68M 819K Sep/2025
Brainstorm Cell Therapeutics USD 11.76M 757K Mar/2026
Capricor Therapeutics USD 33.64M 2.2M Mar/2026
Cara Therapeutics USD 11.04M 2K Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Dr.Reddys Laboratories INR 167.47B 9.16B Mar/2026
Esperion Therapeutics USD 300.36M 451K Mar/2026
Immunic USD 38.36M 7.74M Mar/2026
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Minerva Neurosciences USD 2.29M 381K Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
TherapeuticsMD USD 5.82M 655K Jun/2024
UPL INR 347.48B 16.58B Mar/2026